R. Donald Harvey, PharmD, is an Associate Professor in the Department of Hematology and Medical Oncology in the School of Medicine and Director of the Phase I Clinical Trials Section at the Winship Cancer Institute of Emory University. He obtained his BS and PharmD degrees at the University of North Carolina (UNC) and completed pharmacy practice and hematology oncology residencies at the University of Kentucky and UNC, respectively. His research in anticancer early drug development focuses on the application of clinical pharmacology principles to improved patient care, and he has been principal or co-investigator on over 50 phase I and clinical pharmacology trials since joining Emory in 2009 and has over 60 peer reviewed publications. Organ dysfunction, drug interaction, food effects, and pharmacokinetically driven trials are areas of interest for Dr. Harvey and his group. He is also active in clinical pharmacology and hematology/oncology professional organizations including ASCO, ASCPT, and ASH and is Chair of the Research Committee and a Past President of HOPA.